AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (795.9 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Identification of TMEM217 as a novel prognostic biomarker and potential therapeutic target in acute myeloid leukemia

Yunying Yaoa,1, Zhizhou Xiaa,1, Min Wua, Bo Jiaoa, Jiaming Gaoa, Donghe Lia, Xi Xiea, Pengfei Xua, Jiaoyang Lia, Lei Yana, Ruibao Renb( ), Ping Liua( )
Shanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine, Collaborative Innovation Center of Hematology, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
International Center for Aging and Cancer, Hainan Medical University, Haikou, Hainan 570102, China

1 These authors contributed equally to this work.

Peer review under responsibility of Chongqing Medical University.

Show Author Information

References

【1】
【1】
 
 
Genes & Diseases
Article number: 101037

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Yao Y, Xia Z, Wu M, et al. Identification of TMEM217 as a novel prognostic biomarker and potential therapeutic target in acute myeloid leukemia. Genes & Diseases, 2024, 11(4): 101037. https://doi.org/10.1016/j.gendis.2023.06.010

647

Views

6

Downloads

1

Crossref

1

Web of Science

1

Scopus

0

CSCD

Received: 28 January 2023
Published: 16 July 2023
© 2023 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).